Actively Recruiting
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Led by University of California, San Francisco · Updated on 2025-07-08
2500
Participants Needed
1
Research Sites
1761 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
N
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsor
AI-Summary
What this Trial Is About
SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infection, progression, non-progression, response to treatment, control of HIV-1 virus, and evolution of drug resistance.
CONDITIONS
Official Title
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV-1 infected volunteers meeting any of the following:
- Documented HIV viral load less than 2000 copies/ml without antiretroviral therapy
- Undetectable HIV viral load with CD4 T-cells consistently below 350 for the last 12 months while on stable antiretroviral therapy
- Antiretroviral naive and planning to start therapy, any CD4 or viral load
- Long-term non-progressors: HIV-positive at least 10 years, no antiretroviral therapy for 10 or more years, any viral load, CD4 count always above 500
- Minimum age 18 years
You will not qualify if you...
- Active opportunistic infection or systemic treatment for one within the last 4 months (except oral candidiasis)
- Active treatment for cancer
- Active treatment for hepatitis C requiring interferon-based therapy
- Immunosuppressive therapy within the last 4 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
San Francisco General Hospital
San Francisco, California, United States, 94110
Actively Recruiting
Research Team
R
Rebecca Hoh, M.S., R.D.
CONTACT
M
Montha Pao
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here